Tanshinone IIA attenuates renal fibrosis and inflammation via altering expression of TGF-β/Smad and NF-κB signaling pathway in 5/6 nephrectomized rats

被引:168
作者
Wang, Dong-Tao [1 ]
Huang, Ren-Hua [1 ]
Cheng, Xin [1 ]
Zhang, Zhi-Hua [2 ]
Yang, Ya-Jun [3 ]
Lin, Xin [4 ]
机构
[1] Guangxi Univ Chinese Med, Ruikang Hosp, Dept Nephrol, Nanning 530011, Peoples R China
[2] Gen Hosp Guangzhou Mil Command PLA, Dept Tradit Chinese Med, Guangzhou 510010, Guangdong, Peoples R China
[3] Guangdong Med Coll, Dept Pharmacol, Guangdong Key Lab R&D Nat Drug, Zhanjiang 524023, Peoples R China
[4] Southern Med Univ, Nanfang Hosp, Div Nephrol, Guangzhou 510280, Guangdong, Peoples R China
基金
美国国家科学基金会;
关键词
Tanshinone IIA; Chronic kidney disease; Renal fibrosis; CHRONIC KIDNEY-DISEASE; UNILATERAL URETERAL OBSTRUCTION; GENE-TRANSFER; CRESCENTIC GLOMERULONEPHRITIS; TUBULOINTERSTITIAL FIBROSIS; IN-VIVO; SMAD7; BETA; MICE; INHIBITION;
D O I
10.1016/j.intimp.2015.02.027
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Purpose: In traditional Chinese medicine, Tanshinone HA is used to treat chronic kidney disease (CKD). However, its biological activity and mechanism of action in renal fibrosis and inflammation are not fully identified. The current study was conducted to determine the effects of Tanshinone HA treatment on CKD by assessing potential modulation of the TGF-beta/Smad and NF--kappa B signaling pathway. Methods: CICD was produced in rats by 5/6 nephrectomy. They were then divided into the following groups: control (sham operation); CKD (5/6 nephrectomy); 5/6 nephrectomy + Tanshinone HA (10 mg/kg in average, once a day for 16 weeks). Serum and urine samples were obtained from animals in each group, and serum creatinine (Scr), blood urea nitrogen (BUN) levels and 24 h urinary protein excretion were measured. Tissue samples from the kidney were used for morphometric studies (Masson's trichrome). The expression of fibronectin protein and collagen types 1,111, IV, and TGF-beta, TNF-alpha, CXCL-1, MCP-1, RANTES mRNA were evaluated using immunohistochemistry and RT-PCR analysis; the TGF-beta/Smad and NF-kappa B signaling pathway was detected by immunohistochemistry and Western blot analysis. Results: The following effects were observed in CKD rats treated with Tanshinone IIA: (1) marked improvements in Scr, and 24 h urine protein excretion; (2) significant reductions in protein and mRNA levels of fibronectin, collagen III, and collagen IV and TNF-alpha, MCP-1, and CXCL-1; (3) significantly inhibited the TGF-beta/Smad and NF-kappa B signaling activation. Conclusions: These results suggest that Tanshinone HA suppresses renal fibrosis and inflammation via altering expression of TGF-beta/Smad and NF-kappa B pathway in the remnant kidney, thus supporting the potential of Tanshinone HA as a new therapeutic agent for slowing the progression of CKD. (C) 2015 Elsevier RV. All rights reserved.
引用
收藏
页码:4 / 12
页数:9
相关论文
共 48 条
[1]
Renoprotective Effect of Tanshinone IIA, An Active Component of Salvia miltiorrhiza, on Rats with Chronic Kidney Disease [J].
Ahn, Young-Min ;
Kim, Su Kang ;
Lee, Sang-Hun ;
Ahn, Se-Young ;
Kang, Sung Wook ;
Chung, Joo-Ho ;
Kim, Sung-Do ;
Lee, Byung-Cheol .
PHYTOTHERAPY RESEARCH, 2010, 24 (12) :1886-1892
[2]
TGF-β in renal injury and disease [J].
Bottinger, Erwin P. .
SEMINARS IN NEPHROLOGY, 2007, 27 (03) :309-320
[3]
The Protective Role of Smad7 in Diabetic Kidney Disease: Mechanism and Therapeutic Potential [J].
Chen, Hai Yong ;
Huang, Xiao R. ;
Wang, Wansheng ;
Li, Jin Hua ;
Heuchel, Rainer L. ;
Chung, Arthur C. K. ;
Lan, Hui Yao .
DIABETES, 2011, 60 (02) :590-601
[4]
Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice [J].
Chung, Arthur C. K. ;
Huang, Xiao R. ;
Zhou, Li ;
Heuchel, Rainer ;
Lai, Kar Neng ;
Lan, Hui Y. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (05) :1443-1454
[5]
Smad-dependent and Smad-independent pathways in TGF-β family signalling [J].
Derynck, R ;
Zhang, YE .
NATURE, 2003, 425 (6958) :577-584
[6]
Nuclear factor-κB and the hepatic inflammation-fibrosis-cancer axis [J].
Elsharkawy, Ahmed M. ;
Mann, Derek A. .
HEPATOLOGY, 2007, 46 (02) :590-597
[7]
Chronic inhibition of nuclear factor-κB attenuates renal injury in the 5/6 renal ablation model [J].
Fujihara, Clarice K. ;
Antunes, Glaucia R. ;
Mattar, Ana L. ;
Malheiros, Denise M. A. C. ;
Vieira, Jose M., Jr. ;
Zatz, Roberto .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2007, 292 (01) :F92-F99
[8]
Mice lacking Smad3 are protected against streptozotocin-induced diabetic glomerulopathy [J].
Fujimoto, M ;
Maezawa, Y ;
Yokote, K ;
Joh, K ;
Kobayashi, K ;
Kawamura, H ;
Nishimura, M ;
Roberts, AB ;
Saito, Y ;
Mori, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 305 (04) :1002-1007
[9]
Low-protein diet supplemented with ketoacids reduces the severity of renal disease in 5/6 nephrectomized rats: a role for KLF15 [J].
Gao, Xiang ;
Huang, Lianghu ;
Grosjean, Fabrizio ;
Esposito, Vittoria ;
Wu, Jianxiang ;
Fu, Lili ;
Hu, Huimin ;
Tan, Jiangming ;
He, Cijian ;
Gray, Susan ;
Jain, Mukesh K. ;
Zheng, Feng ;
Mei, Changlin .
KIDNEY INTERNATIONAL, 2011, 79 (09) :987-996
[10]
A Purpose-Synthesised Anti-Fibrotic Agent Attenuates Experimental Kidney Diseases in the Rat [J].
Gilbert, Richard E. ;
Zhang, Yuan ;
Williams, Spencer J. ;
Zammit, Steven C. ;
Stapleton, David I. ;
Cox, Alison J. ;
Krum, Henry ;
Langham, Robyn ;
Kelly, Darren J. .
PLOS ONE, 2012, 7 (10)